WOBURN, MA, February 7, 2022 – Azurity Pharmaceuticals, Inc., a private specialty pharmaceutical company, focused on developing innovative products to meet the unique needs of patients with underserved conditions, today announced the U.S. Food…Original Article
FDA Approves Fleqsuvy (baclofen oral suspension) for the Treatment of Spasticity
